Comprehensive Industry Report Offers Forecast and Analysis on Glaucoma Market by 2026 - Novartis AG, Allergan Inc., Merck & Co., Akron Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer Inc., Santen
Glaucoma is the second most common leading cause of blindness and is commonly observed in the older population. This disease damages the optic nerve, which happens due to extra fluid that is built in front of eye, resulting in increased pressure on eye. Glaucoma is generally characterized by symptoms such as tunnel vision, eye pain, blurred vision, and red eyes.
The clear liquid that is present in and out of anterior chamber nourishes nearby tissue in the eye. Generally, there are two types of glaucoma namely; Primary open-angle glaucoma and angle-closure glaucoma. Primary open-angle glaucoma is the most common type of glaucoma which is found in the iris located very close to the drainage angle in the eye. The treatment of glaucoma majorly focuses on the improving fluid flow in the eyes or reducing its production. Majorly used eye drops include prostaglandin analogues, cholinergic agents, and beta blockers. Even though, with high adoption rate the eye drops have relative side effects that lead to chronic disorders like kidney stone, weight loss, impotence, and fatigue.
Request Sample Pages for more Professional and Technical insights @
Glaucoma Market is driven by the factors such as increasing geriatric population and increasing demand for the combination drugs by end users.
The growth in Glaucoma Market is primarily driven by the increasing number of fixed-dose combination that are used for treating glaucoma and increasing geriatric population. Additionally, increasing awareness for diagnosis of glaucoma at the initial stage is also resulting in growth of this entire industry. Also, development of new phase drugs by the biopharmaceutical companies and government initiatives for supporting the drug development is expected to increase the market for glaucoma during the forecast period. Moreover, rapid technological advancements in the devices that are used in surgeries would also stimulate the growth of this market.
However, lack of awareness about glaucoma treatment by using various surgical devices across developing countries would impede the growth of Glaucoma Market in the near future.
Key players in the Glaucoma Market are:
• Novartis AG
• Allergan Inc.
• Merck & Co.
• Akron, Inc.
• Bausch & Lomb Incorporated
• Teva Pharmaceuticals
• Pfizer Inc.
• Aerie Pharmaceuticals
• Inotek Pharmaceuticals
• Essilor International SA
• Hoya Corporation
• Sonomed Escalon
• Carl Zeiss Meditec AG
• HumanOptics AG
For 'Queries' related to this research report, Make an Enquiry @
On the basis of geography, North America region is expected to dominate the Glaucoma Market over the forecast period. The primary factor influencing growth of market in this region is rise in observance of glaucoma among the increasing geriatric population. Additionally, availability of key manufacturers and heavy investment on research and development by the government towards glaucoma is expected to have a positive impact on the growth of market in North America. On the other hand, increased awareness for the use of these drugs also promotes market growth in the near future. While, Europe region is observed to hold the second largest market share in this market.
However, Asia Pacific is observed to grow at a faster rate during forecast period. Increasing awareness for the use of new drugs, improving economic settings by the key payers for focussing on the untapped market, and growing government concern for promoting minimal invasive surgeries are the major factors resulting in growth of Glaucoma Market in Asia Pacific during upcoming years.
Table of Content of Glaucoma Market:
Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Glaucoma Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Corporate Sales, USA
Polaris Market Research and Consulting
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Industry Report Offers Forecast and Analysis on Glaucoma Market by 2026 - Novartis AG, Allergan Inc., Merck & Co., Akron Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer Inc., Santen here
News-ID: 1350142 • Views: 1369
More Releases from Polaris Market Research & Consulting
What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,
More Releases for Glaucoma
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1159 The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the
Glaucoma Treatment Pharmaceutical and Healthcare Analysis Information
Report Description This report analyzes the Asia-pacific glaucoma treatment market by disease indication (closed angle glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other), drug class (prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others), surgery (laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy) and by end users (hospitals and home users); it also studies the top manufacturers in the
Market Overview of Glaucoma pipeline Landscape
Summary Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin cornea, family history of glaucoma. Signs and symptoms include eye pain, nausea and vomiting (accompanying the severe
Market Spotlight: Glaucoma
Boston, MA ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports. Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and
Can yoga worsen glaucoma?
Patients with glaucoma are encouraged to exercise and lead healthy and active lifestyle, but should avoid activities that increase the eye pressure and damage the optic nerve. Push-ups and heavy weight lifting are not advisable, so is certain yoga postures in which the head is facing downward. Previous studies have investigated only headstand position which showed a remarkable two-fold increase in eye pressure. However, a new research carried out at